Temporal Characteristics of Device-Based Individual and Integrated Risk Metrics in Patients With Chronic Heart Failure

被引:9
|
作者
Zile, Michael R. [1 ,2 ,6 ]
Kahwash, Rami [3 ]
Sarkar, Shantanu [4 ]
Koehler, Jodi [4 ]
Butler, Javed [5 ]
机构
[1] Med Univ South Carolina, Charleston, SC 29425 USA
[2] Ralph H Johnson Dept Vet Affairs Med Ctr, Charleston, SC USA
[3] Ohio State Univ, Columbus, OH USA
[4] Medtronic, Minneapolis, MN USA
[5] Univ Mississippi, Jackson, MS USA
[6] Med Univ South Carolina, Dept Med, Div Cardiol, Room 323, 30 Courtenay Dr, Charleston, SC 29425 USA
关键词
KEY WORDS heart failure; hemodynamics; risk metrics; ATRIAL-FIBRILLATION; HOSPITALIZATION; READMISSION; DIAGNOSTICS; HF;
D O I
10.1016/j.jchf.2022.10.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Temporal characteristics of a multimetric risk score and its individual parameters before, during, and after a heart failure (HF) event have not been defined. OBJECTIVES A large real-world patient cohort with implantable cardioverter-defibrillators and cardiac resynchronization therapy (CRT) defibrillators was used to define these temporal characteristics. METHODS Deidentified health records were linked to manufacturer's device database in 17,886 patients. Multimetric risk score combined daily measures of impedance, heart rate, activity, heart rate variability, and atrial fibrillation (AF) burden, AF ventricular rate, CRT pacing, and ventricular tachycardia episodes and shocks. HF event was defined as an inpatient, emergency department, or observation unit stay with primary diagnosis of HF and intravenous diuretic agents administration. Changes in risk parameters during 60 days before, during, and after an HF event were compared in patients with no HF readmissions vs patients with HF readmission. RESULTS A total of 1,174 patients had HF events with no HF readmission, and 282 patients had HF events with HF readmission. Diagnostic risk score was higher on all 60 days before and after a HF event in patients with HF read-mission compared with patients with no readmission (P < 0.001). Change in risk score from admission to discharge was similar in patients with and without HF readmission, but the risk score fell more significantly 7 after discharge and 30 days after admission in patients without HF readmission (P < 0.001). CONCLUSIONS Temporal characteristics of risk metrics were significantly different in patients with no HF readmissions vs patients with HF readmission; patients without HF recurrence had larger recovery of risk metrics values toward normal. (J Am Coll Cardiol HF 2023;11:143-156) (c) 2023 by the American College of Cardiology Foundation.
引用
收藏
页码:143 / 156
页数:14
相关论文
共 50 条
  • [21] Feasibility of a new device-based approach for treating diastolic heart failure
    Dubi, S.
    Feld, Y.
    Shofti, R.
    Pinhasi, A.
    Schwammenthal, E.
    Elami, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2007, 6 : 115 - 115
  • [22] Device-Based Nonspecific Immunomodulation Therapy (Celacade), and Its Potential Role in the Treatment of Chronic Heart Failure
    Sporter, Robert J.
    Kim, Joon-Hyuk
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2008, 16 (06) : 280 - 287
  • [23] Implantable device-based monitoring of patients with heart failure: The OptiVol users' summit 2006 - Introduction
    Tang, W. H. Wilson
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (10A): : 1G - 2G
  • [24] Is There a Logic in Using Device-Based Algorithms to Prevent Heart Failure Decompensations?
    Klein, Liviu
    CIRCULATION-HEART FAILURE, 2021, 14 (10) : 1080 - 1082
  • [25] Changes in device-based thoracic impedance in decompensating congestive heart failure
    Yu, CM
    Lau, CP
    Tang, MO
    Chau, E
    Lam, WF
    Lee, PY
    Kong, SL
    Yuen, F
    Christensen, J
    Wang, L
    Olson, WH
    CIRCULATION, 2001, 104 (17) : 419 - 419
  • [26] Device-based treatment options for heart failure with preserved ejection fraction
    Chihiro Miyagi
    Takuma Miyamoto
    Jamshid H. Karimov
    Randall C. Starling
    Kiyotaka Fukamachi
    Heart Failure Reviews, 2021, 26 : 749 - 762
  • [27] Innovative Device-Based Strategies for Managing Acute Decompensated Heart Failure
    Bertolone, Dario Tino
    Paolisso, Pasquale
    Gallinoro, Emanuele
    Belmonte, Marta
    Bermpeis, Konstantinos
    De Colle, Cristina
    Caglioni, Serena
    Fabbricatore, Davide
    Leone, Attilio
    Valeriano, Chiara
    Shumkova, Monika
    Storozhenko, Tatyana
    Viscusi, Michele Mattia
    Botti, Giulia
    Verstreken, Sofie
    Morisco, Carmine
    Barbato, Emanuele
    Bartunek, Jozef
    Vanderheyden, Marc
    CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (12)
  • [28] Remote Monitoring of Heart Failure Using A Device-Based Multisensor Algorithm
    Chang, Andrew
    Yang, Yang
    Giorgberidze, Irakli
    Afshar, Hamid
    Schurmann, Paul
    Misra, Arunima
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S55 - S55
  • [29] Device-Based Remote Monitoring as Contemporary Heart Failure Disease Management: Baseline Characteristics of Patients Enrolled in the OptiVol Care Pathway Study
    Tang, W. H. Wilson
    Small, Roy S.
    Heywood, J. Thomas
    andriulli, John
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (08) : S69 - S69
  • [30] Heart Failure Patients With Dyspnea Had Higher Device-Based Respiratory Rate Than Those Without
    Gardner, Roy S.
    Merkely, Bela
    Lambiase, Pier
    Zhang, Yi
    An, Qi
    Averine, Viktoria
    Sweeney, Robert
    Wehrenberg, Scott
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (08) : S132 - S133